{"id":607948,"date":"2022-07-13T19:30:01","date_gmt":"2022-07-13T19:30:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=607948"},"modified":"2022-07-13T19:30:01","modified_gmt":"2022-07-13T19:30:01","slug":"agerelated-macular-degeneration-therapeutics-pipeline-assessment-latest-fda-and-eu-approvals-breakthroughs-clinical-trials-emerging-therapies-ribomic-amgen-kodiak-sciences-graybug-vision","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/agerelated-macular-degeneration-therapeutics-pipeline-assessment-latest-fda-and-eu-approvals-breakthroughs-clinical-trials-emerging-therapies-ribomic-amgen-kodiak-sciences-graybug-vision_607948.html","title":{"rendered":"Age-related Macular Degeneration Therapeutics Pipeline Assessment | Latest FDA and EU Approvals, Breakthroughs, Clinical Trials, Emerging Therapies | Ribomic, Amgen, Kodiak Sciences, Graybug Vision"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1585677425.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Age-related Macular Degeneration Therapeutics Pipeline Assessment | Latest FDA and EU Approvals, Breakthroughs, Clinical Trials, Emerging Therapies | Ribomic, Amgen, Kodiak Sciences, Graybug Vision\" src=\"https:\/\/www.abnewswire.com\/uploads\/1585677425.jpeg\" alt=\"Age-related Macular Degeneration Therapeutics Pipeline Assessment | Latest FDA and EU Approvals, Breakthroughs, Clinical Trials, Emerging Therapies | Ribomic, Amgen, Kodiak Sciences, Graybug Vision\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Delveinsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Age-related Macular Degeneration is a disease that damages the retina and affects a person\u2019s central vision due to which the images that used to be clear start appearing blurred, and dark spots may appear, which get progressively bigger. AMD mainly affects a smaller area near the center of the retina, called the macula, which is needed for detailed tasking such as reading, driving, etc.<\/div>\n<p style=\"text-align: justify;\" dir=\"ltr\">Globally, several key companies are actively working in the Age-related Macular Degeneration Therapeutics Market. The launch of the emerging therapies is expected to transform the treatment scenario in the coming years.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><em>&ldquo;<strong>Age-related Macular Degeneration Pipeline Insight, 2022<\/strong>&#8221; report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Age-related Macular Degeneration Market.&nbsp;<\/em><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">The <strong>Age-related Macular Degeneration Pipeline<\/strong> report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers, acquisition, funding, designations, and other product-related details.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/uploads\/003d2274dfb191e14e8ede1c8a803a04.jpg\" alt=\"\" \/><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/age-related-macular-degeneration-amd-pipeline-insight?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\" target=\"_blank\"><strong>Age-related Macular Degeneration Pipeline Analysis<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>The report provides insights into:&nbsp;<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">The report provides detailed insights about companies that are developing therapies for the <strong>treatment of Age-related Macular Degeneration<\/strong> with aggregate therapies developed by each company for the same.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for the<strong> Age-related Macular Degeneration Treatment<\/strong>.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Age-related Macular Degeneration key companies<\/strong> involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Age-related Macular Degeneration Drugs<\/strong> under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the <strong>Age-related Macular Degeneration market<\/strong>.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\">The report is built using data and information traced from the researcher&#8217;s proprietary databases, company\/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company\/university websites and industry-specific third-party sources, etc.&nbsp;&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Request for Sample PDF Report &#8211;&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/age-related-macular-degeneration-amd-pipeline-insight?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\" target=\"_blank\">https:\/\/www.delveinsight.com\/sample-request\/age-related-macular-degeneration-amd-pipeline-insight<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Age-related Macular Degeneration Therapeutics Landscape &#8211;<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Age-related Macular Degeneration Mechanism of Action (MOA):<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Placenta growth factor inhibitors<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Vascular endothelial growth factor A inhibitors<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Angiogenesis inhibitors<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Colony stimulating factor receptor antagonists<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Vascular endothelial growth factors inhibitors<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Fibroblast growth factor inhibitors<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Cell replacements<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Age-related Macular Degeneration (AMD) Therapies covered in the report include:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">GB-102<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">KSI 301<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">ADVM-022<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">OpRegen<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">ABP 938<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">RBM-007 Injectable Solution<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\">And many more.&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Some of the Key Companies in the Age-related Macular Degeneration (AMD) Market include:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Ribomic USA Inc.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Amgen<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Lineage Cell Therapeutics, Inc.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Adverum Biotechnologies, Inc<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Kodiak Sciences Inc.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Graybug Vision<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\">And many others.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Get More Detailed Insights Into the Emerging Therapies &amp; Key Companies:&nbsp; <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/age-related-macular-degeneration-amd-pipeline-insight?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\" target=\"_blank\">https:\/\/www.delveinsight.com\/sample-request\/age-related-macular-degeneration-amd-pipeline-insight<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Table of Content (TOC)<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">1. Report Introduction<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">2. Executive Summary<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">3. Age-related Macular Degeneration Current Treatment Patterns<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">4. Age-related Macular Degeneration &#8211; DelveInsight&#8217;s Analytical Perspective<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">5. Therapeutic Assessment<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">6. Age-related Macular Degeneration Late Stage Products (Phase-III)<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">7. Age-related Macular Degeneration Mid-Stage Products (Phase-II)<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">8. Age-related Macular Degeneration Early Stage Products (Phase-I)<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">9. Pre-clinical Products and Discovery Stage Products<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">10. Inactive Products<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">11. Dormant Products<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">12. Age-related Macular Degeneration Discontinued Products<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">13. Age-related Macular Degeneration Product Profiles<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">14. Key Companies in the Age-related Macular Degeneration Market<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">15. Key Products in the Age-related Macular Degeneration Therapeutics Segment<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">16. Dormant and Discontinued Products<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">17. Age-related Macular Degeneration Unmet Needs<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">18. Age-related Macular Degeneration Future Perspectives<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">19. Age-related Macular Degeneration Analyst Review&nbsp;&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">20. Appendix<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">21. Report Methodology<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><em>*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.<\/em><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Download Sample PDF Report &#8211;&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/age-related-macular-degeneration-amd-pipeline-insight?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\" target=\"_blank\">https:\/\/www.delveinsight.com\/sample-request\/age-related-macular-degeneration-amd-pipeline-insight<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>About DelveInsight<br \/><\/strong>DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Other Trending Healthcare Reports by DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/structural-heart-devices-market-market\">Structural Heart Devices Market<br \/><\/a><\/strong>&#8220;Structural Heart Devices Market&#8221; research report provides comprehensive insights into the historical and forecasted&nbsp;Structural Heart Devices market size, share, trends as well as the key companies and emerging products in the market.&nbsp;&nbsp;<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56421.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Anuj Rawat<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=agerelated-macular-degeneration-therapeutics-pipeline-assessment-latest-fda-and-eu-approvals-breakthroughs-clinical-trials-emerging-therapies-ribomic-amgen-kodiak-sciences-graybug-vision\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 09650213330<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> NV<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=agerelated-macular-degeneration-therapeutics-pipeline-assessment-latest-fda-and-eu-approvals-breakthroughs-clinical-trials-emerging-therapies-ribomic-amgen-kodiak-sciences-graybug-vision\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Delveinsight Business Research LLP Age-related Macular Degeneration is a disease that damages the retina and affects a person\u2019s central vision due to which the images that used to be clear start appearing blurred, and dark spots may appear, which get &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/agerelated-macular-degeneration-therapeutics-pipeline-assessment-latest-fda-and-eu-approvals-breakthroughs-clinical-trials-emerging-therapies-ribomic-amgen-kodiak-sciences-graybug-vision_607948.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[425,426,405,417,406],"tags":[],"class_list":["post-607948","post","type-post","status-publish","format-standard","hentry","category-Finance","category-Financial-Market","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/607948","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=607948"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/607948\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=607948"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=607948"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=607948"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}